Primary Specialty
Movement Disorders
Insurance
For specific plans, see the full plan list. To be sure this medical professional is covered by your insurance plan, please contact your insurance carrier.
Practice Focus Areas
- Botox Injections (Botulinum Toxin)
- Dystonia
- Essential Tremor
- Lewy Body Dementia
- Neurogenetic Movement Disorders
- Parkinson's Disease
- Progressive Supranuclear Palsy (PSP)
Education
- Medical Education:
-
MD, St Petersburg State Pediatric Medical University - 1985
- Internship:
-
Albert Einstein Healthcare Network - 1991
- Residency:
-
Temple University Hospital - 1994
- Fellowships:
-
Temple University Hospital - 1995University of Pennsylvania Health System - 1996
Languages Spoken
- Russian
Board Certifications
- American Board of Psychiatry and Neurology - Neurology (Certified)
Faculty Profile
Professor, Feinberg School of MedicinePractice Groups and Affiliations
- Medical Group:
- Northwestern Medical Group
- Alignment Category:
-
Northwestern Medicine Physician Network
- On Medical Staff At:
-
Northwestern Memorial Hospital
Ratings and Reviews
At Northwestern Medicine, our patient’s feedback is important to us. While different care providers have their own unique strengths, we strive to be as transparent as possible with our quality of care.
Read Ratings FAQsOverall Rating
173 Ratings
Reviews from Patients
Reviews from Patients
January 03, 2022
5.0 star star star star starShe takes the time to listen before diagnosing. If you don’t understand, she tries to explain in a different way. Extremely knowledgeable, not hesitant to discuss recent studies, things that are new and upcoming. Provides options, with a thoughtful evaluation of what you have come up with.
December 06, 2021
5.0 star star star star starIn addition to her top reputation in movement disorders, she takes personal interest in her patients. She always listens to your questions and concerns. She never seems rushed with patients even though I’m sure she is very busy.
Disclosures
Industry Relationships
Ownership or Investment Interests
Faculty member had an ownership or investment interest in the following companies
- Sinopia Biosciences, Inc.
Consulting / Related Activities
Faculty member engaged in activities such as speaking, advising, consulting, or providing educational programs for the following companies or other entities
- 4D Pharma PLC
- Acadia Pharmaceuticals, Inc.
- Amneal Pharmaceuticals, Inc. (formerly Impax Laboratories)
- BIAL
- BlueRock Therapeutics
- Caraway Therapeutics, Inc.
- CME Group, Inc.
- Critical Path Institute
- Department of Defense (DoD)
- Enterin Inc.
- Hancom MDS Inc.
- Leidos
- Medlance
- NeuroDerm Ltd.
- Parkinson Study Group
- Psychiatry Continuing Medical Education
- Roche (F. Hoffmann-La Roche, Ltd.)
- Sanofi Genzyme
- Sinopia Biosciences, Inc.
- Sunovion Pharmaceuticals Canada, Inc.
- Takeda Pharmaceuticals North America, Inc.
- The Michael J. Fox Foundation
- UCB Pharma (UCB S.A., Belgium)
- University of Rochester
External Professional Relationships
Pharmaceutical, device, and biotechnology companies frequently collaborate with basic scientists and physicians within an academic medical center to help advance science and improve patient care. These relationships are important in achieving scientific breakthroughs and in establishing the effectiveness and safety of promising new therapies. In order to assure objectivity in clinical research and patient care, the Northwestern University Feinberg School of Medicine (Feinberg), Northwestern Memorial HealthCare, Children's Hospital of Chicago Medical Center, and the Shirley Ryan AbilityLab have adopted integrity policies that require research and clinical faculty (in full-time, part-time, and unpaid/voluntary categories) to report compensated and uncompensated external industry relationships. Patients are encouraged to discuss these disclosures with their physician as well as to inquire as to how these relationships are overseen by Feinberg. To learn more about our Disclosure and Professional Integrity Policy, and the conflict of interest policies of our joint affiliate survey partners, please go to our Office for Regulatory Affairs Policies page.